GlobeNewswire Inc | Apr 7, 2021 08:00AM EDT

April 07, 2021

SAN DIEGO, April 07, 2021 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics designed to transform the standard of care for patients facing serious fungal or viral infections, today announced thatJeffrey Stein, Ph.D., President and Chief Executive Officer, will present a corporate overview at the 20th Annual Needham Virtual Healthcare Conference on Wednesday, April 14, 2021.

Presentation Information:Date: Wednesday, April 14, 2021Time: 1:30 PM ETWebcast: A live audio webcast and replay of the presentation will be available in theInvestors section on the company?s website at www.cidara.com.

About Cidara TherapeuticsCidara is developing long-acting therapeutics designed to transform the standard of care for patients facing serious fungal or viral infections. The Companys portfolio is comprised of its lead antifungal candidate, rezafungin, in addition to antiviral conjugates (AVCs) for the prevention and treatment of influenza and other viral diseases from Cidaras proprietary Cloudbreak antiviral platform. Cidara is headquartered in San Diego, California. For more information, please visitwww.cidara.com.

INVESTOR CONTACT:Brian RitchieLifeSci Advisors(212) 915-2578britchie@lifesciadvisors.com

MEDIA CONTACT:Patrick BurseyLifeSci Communications(203) 430-9545pbursey@lifescicomms.com